Inhibitory effects of alprazolam on the development of acute experimental autoimmune encephalomyelitis in stressed rats

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 2, 2010, Pages 350-356

  Núñez Iglesias, María J ^a   Novío, Silvia ^a   Almeida Dias, Antonio ^a   Freire Garabal, Manuel ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Anxiety; Anxiolitic benzodiazepine agonist; Autoimmmune nervous system disease; Corticosterone; Experimental autoimmune encephalomyelitis

Indexed keywords

ALPRAZOLAM; CORTICOSTERONE; FREUND ADJUVANT; MYELIN BASIC PROTEIN; PLACEBO;

ACOUSTIC STRESS; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE SEVERITY; HISTOPATHOLOGY; MALE; MYCOBACTERIUM TUBERCULOSIS; MYELITIS; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

ALPRAZOLAM; ANIMALS; ANTI-ANXIETY AGENTS; BODY WEIGHT; CORTICOSTERONE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FREUND'S ADJUVANT; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MYCOBACTERIUM TUBERCULOSIS; NOISE; RATS; RATS, INBRED LEW; SPINAL CORD; STRESS, PSYCHOLOGICAL;

MYCOBACTERIUM TUBERCULOSIS; RATTUS;

EID: 77957804582     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.09.002     Document Type: Article

References (62)

1. Ackerman K.D., Heyman R., Rabin B.S., Anderson B.P., Houck P.R., Frank E., et al. Stressful life events precede exacerbations of multiple sclerosis. Psychosom Med 2002, 64:916-920.
2. Ackerman K.D., Stover A., Heyman R., Anderson B.P., Houck P.R., Frank E., et al. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav Immun 2003, 17:141-151.
3. Acuña D., Fernandez B., Gomar M.D., del Aguila C.M., Castillo J.L. Influence of the pituitary-adrenal axis on benzodiazepine receptor binding to rat cerebral cortex. Neuroendocrinology 1990, 51:97-103.
4. Ahmed Z., Gveric D., Pryce G., Baker D., Leonard J.P., Cuzner M.L., et al. Myelin/axonal pathology in interleukin-12 induced serial relapses of experimentalallergic encephalomyelitis in the Lewis rat. Am J Pathol 2001, 158:2127-2138.
5. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009, 34:4-20.
6. Arvat E., Giordano R., Grottoli S., Ghigo E. Benzodiazepines and anterior pituitary function. J Endocrinol Invest 2002, 25:735-747.
7. Bernard C.C.A., Mandel T.E., Mackay I.R. Experimental models of human autoimmune disease: overview and prototypes. The Autoimmune Diseases II 1992, 47-106. Academic Press, London. N. Rose, I.R. Mackay (Eds.).
8. Bernardini R., Calogero A.E., Ehrlich Y.H., Brucke T., Chrousos G.P., Gold P.W. The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 1989, 125:1067-1073.
9. Bizzi A., Ricci M.R., Veneroni E., Amato M., Garattini S. Benzodiazepine receptor antagonists reverse the effect of diazepam on plasma corticosterone in stressed rats. J Pharm Pharmacol 1984, 36:134-135.
10. Bolton C., Paul C. MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J Pharmacol Exp Ther 1997, 282:397-402.
11. Brown R.F., Tennant C.C., Dunn S.M., Pollard J.D. A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables. Mult Scler 2005, 11:477-484.
12. Brown R.F., Tennant C.C., Sharrock M., Hodgkinson S., Dunn S.M., Pollard J.D. Relationship between stress and relapse in multiple sclerosis: part II. Direct and indirect relationships. Mult Scler 2006, 12:465-475.
13. Bukilica M., Djordjevic S., Maric I., Dimitrijevic M., Markovic B.M., Jankovic B.D. Stress-induced suppression of experimental allergic encephalomyelitis in the rat. Int J Neurosci 1991, 59:167-175.
14. Chang M.P., Castle S.C., Norman D.C. Mechanism of immunosuppressive effect of alprazolam: alprazolam suppresses T-cell proliferation by selectively inhibiting the production of IL2 but not acquisition of IL2 receptor. Int J Immunopharmacol 1992, 14:227-237.
15. Chrousos G.P. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000, 24:S50-S55.
16. Cross A.H., Cannella B., Brosnan C.F., Raine C.S. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 1990, 63:162-170.
17. Del Rey A., Klusman I., Besedovsky H.O. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1. Am J Physiol 1998, 275:R1146-R1151.
18. Dimitrijevic M., Markovic B.M., Laban O., Jankovic B.D. Suppression of experimental allergic encephalomyelitis in offspring of DA and Wistar rats following immunization of mother with encephalitogen. J Neuroimmunol 1995, 58:43-50.
19. Dowdell K.C., Gienapp I.E., Stuckman S., Wardrop R.M., Whitacre C.C. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic-pituitary-adrenal axis. J Neuroimmunol 1999, 100:243-251.
20. Fife B.T., Huffnagle G.B., Kuziel W.A., Karpus W.J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 2000, 192:899-905.
21. Geczy C.L., Roberts I.M., Meyer P., Bernard C.C. Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities. J Immunol 1984, 133:3026-3036.
22. Golan D., Somer E., Dishon S., Cuzin-Disegni L., Miller A. Impact of exposure to war stress on exacerbations of multiple sclerosis. Ann Neurol 2008, 64:143-148.
23. Gold S.M., Mohr D.C., Huitinga I., Flachenecker P., Sternberg E.M., Heesen C. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 2005, 26:644-652.
24. Goodin D.S. The impact of war-stress on MS exacerbations. Ann Neurol 2008, 64:114-115.
25. Grant I., Brown G.W., Harris T., McDonald W.I., Patterson T., Trimble M.R. Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989, 52:8-13.
26. Griffin A.C., Lo W.D., Wolny A.C., Whitacre C.C. Suppression of experimental autoimmune encephalomyelitis by restraint stress: sex differences. J Neuroimmunol 1993, 44:103-116.
27. Hung Y.Y., Huang T.L. Lorazepam and diazepam for relieving catatonic features in multiple sclerosis. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1537-1538.
28. Inoue A., Koh C.S., Shimada K., Yanagisawa N., Yoshimura K. Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats. J Neuroimmunol 1996, 71:131-137.
29. Izikson L., Klein R.S., Charo I.F., Weiner H.L., Luster A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000, 192:1075-1080.
30. Juedes A.E., Hjelmström P., Bergman C.M., Neild A.L., Ruddle N.H. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 2000, 164:419-426.
31. Karpus W.J., Kennedy K.J. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol 1997, 62:681-687.
32. Karpus W.J., Ransohoff R.M. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 1998, 161:2667-2671.
33. Kornecki E., Ehrlich Y.H., Lenox R.H. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science 1984, 226:1454-1456.
34. Kornecki E., Lenox R.H., Hardwick D.H., Bergdahl J.A., Ehrlich Y.H. Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. Adv Exp Med Biol 1987, 221:477-488.
35. Liu T., Donahue K.C., Hu J., Kurnellas M.P., Grant J.E., Li H. Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord. J Proteome Res 2007, 6:2565-2575.
36. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8:500-508.
37. MacPhee I.A., Antoni F.A., Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989, 169:431-445.
38. Marchetti B., Morale M.C., Testa N., Tirolo C., Caniglia S., Amor S., et al. Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA. Brain Res Brain Res Rev 2001, 37:259-272.
39. Mohr D.C., Goodkin D.E., Nelson S., Cox D., Weiner M. Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom Med 2002, 64:803-809.
40. Mohr D.C., Hart S.L., Julian L., Cox D., Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004, 328:731. 10.1136/bmj.38041.724421.55.
41. Monjan A.A., Collector M.I. Stress-induced modulation of the immune response. Science 1977, 196:307-308.
42. Ng D.S., Wong K. Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. Biochem Biophys Res Commun 1988, 155:311-316.
43. Nisipeanu P., Korczyn A.D. Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993, 43:1311-1312.
44. Nuñez M.J., Balboa J., Rey-Méndez M., Brenlla J., González-Peteiro M., Rodrigo E., et al. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats. Hum Exp Toxicol 2007, 26:637-643.
45. Oda T., Ueda A., Shimizu N., Handa H., Kasahara T. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region. J Immunol 2002, 169:3329-3335.
46. Owens M.J., Bissette G., Nemeroff C.B. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 1989, 4:196-202.
47. Owhashi M., Shouzui Y., Arita H. Stress down-regulates experimental allergic encephalomyelitis (EAE) but permits activation and localization of autoreactive V beta 8.2+ T cells. Int J Neurosci 1997, 89:177-188.
48. Pratt R.T.C. An investigation of the psychiatric aspects of disseminated sclerosis. J Neurol Neurosurg Psychiatry 1951, 14:326-336.
49. Ransohoff R.M. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J Neuroimmunol 1999, 98:57-68.
50. Rode G., Maupas E., Luaute J., Courtois-Jacquin S., Boisson D. Medical treatment of spasticity. Neurochirurgie 2003, 49:247-255.
51. Sibley W.A. Risk factors in multiple sclerosis. Multiple Sclerosis: Clinical and Pathogenetic Basis 1997, 141-148. Chapman and Hall, London. C.S. Raine, H.F. McFarland, W.W. Tourtellotte (Eds.).
52. Sibley W.A., Bamford C.R., Clark K., Smith M.S., Laguna J.F. A prospective study of physical trauma and multiple sclerosis. J Neurol Neurosurg Psychiatry 1991, 54:584-589.
53. Simpson J.E., Newcombe J., Cuzner M.L., Woodroofe M.N. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 1998, 84:238-249.
54. Stanislaus R., Singh A.K., Singh I. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res 2001, 66:155-162.
55. Steinman L., Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 2006, 60:12-21.
56. Stip E., Truelle J.L. Organic personality syndrome in multiple sclerosis and effect of stress on recurrent attacks. Can J Psychiatry 1994, 39:27-33.
57. Tanuma N., Shin T., Matsumoto Y. Characterization of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats. J Neuroimmunol 2000, 108:171-180.
58. Then Bergh F., Kümpfel T., Trenkwalder C., Rupprecht R., Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 1999, 53:772-777.
59. Warren S., Greenhill S., Warren K.G. Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship. J Chron Dis 1982, 35:821-831.
60. Welsh C.J., Steelman A.J., Mi W., Young C.R., Storts R., Welsh T.H., et al. Neuroimmune interactions in a model of multiple sclerosis. Ann NY Acad Sci 2009, 1153:209-219.
61. Whitacre C.C., Dowdell K., Griffin A.C. Neuroendocrine influences on experimental autoimmune encephalomyelitis. Ann NY Acad Sci 1998, 840:705-716.
62. Zenker N., Bernstein D.E. The estimation of small amounts of corticosterone in rat plasma. J Biol Chem 1958, 231:695-701.